Author:
Ahmed Tanvir,Svennerholm Ann-Mari,Tarique Abdullah Al,Sultana Gazi N.N.,Qadri Firdausi
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference33 articles.
1. Changing profile of Vibrio cholerae O1, O139 in Delhi and its periphery (2003–2005);Sharma;Indian J Med Res,2007
2. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries;Walker;Vaccine,2005
3. B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity;Clemens;J Infect Dis,1987
4. Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants;Qadri;Vaccine,2007
5. Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area;Richie;Vaccine,2000
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Perspective on the Strategy for Advancing ETVAX®, An Anti-ETEC Diarrheal Disease Vaccine, into a Field Efficacy Trial in Gambian Children: Rationale, Challenges, Lessons Learned, and Future Directions;Microorganisms;2023-12-31
2. Mucosal and systemic immune responses to Vibrio cholerae infection and oral cholera vaccines (OCVs) in humans: a systematic review;Expert Review of Clinical Immunology;2022-10-28
3. Diagnosis, Management, and Future Control of Cholera;Clinical Microbiology Reviews;2022-09-21
4. Changes in Systemic Regulatory T Cells, Effector T Cells, and Monocyte Populations Associated With Early-Life Stunting;Frontiers in Immunology;2022-06-02
5. Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges;Immunity, Inflammation and Disease;2022-03-10